CClinicalTrials.gg
CompletedNCT04893265INFORMEDUpdated May 14, 2025Results posted

Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination

An interventional study of Text Messaging Only and INFORMED in Educational Activities, sponsored by University of California, San Francisco. Completed at 3 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-14.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
247
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study develops and evaluates the "INdividual and Family-Oriented Responsive Messaging EDucation" (INFORMED) intervention in increasing knowledge about COVID-19 testing and decreasing decisional conflicts of getting tested for COVID-19. A 2-arm randomized controlled trial will compare INFORMED delivered by LHW educational outreach plus Short Message Service (SMS) text messaging to SMS text with LHW support.

Read the detailed description

This project "Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccinations" is to identify and address sociocultural, ethical and behavioral barriers related to Coronavirus Disease 2019 (COVID-19) testing and vaccination to enable Asian Americans to make well-informed decisions about getting tested for COVID-19. Asian Americans have experienced high rates of COVID-19 related hospitalization and mortality rates when compared to non-Hispanic whites particularly among those who tested positive. Excess COVID-19 related deaths observed in Asian Americans are in part due to under-testing or delayed testing. Asian Americans may face multiple challenges, including sociocultural (limited English proficiency, lack of trust, excess fears and social stigma related COVID-19), ethical (lack of proven benefits of various guidelines, unequal access to testing resources), and behavioral (tobacco and e-cigarette use, other competitive behaviors) factors. The pandemic is rapidly evolving and presents urgent needs to develop highly efficient channels to communicate accurate, easily comprehensive, cultural appropriate and practical information. This application is a supplement to a parent R01 "A Family-Focused Intervention for Asian American Male Smokers," as known to the public as a community-based intervention research program "Healthy Family Project." Leveraging the community partnerships and the individual / family-based LHW intervention approaches developed by the study team, the proposed aims are: (1)Develop and evaluate "INdividual and Family-Oriented Responsive Messaging EDucation" (INFORMED) intervention in increasing knowledge about COVID-19 testing and decreasing decisional conflicts of getting tested for COVID-19. A 2-arm randomized controlled trial will compare INFORMED delivered by LHW educational outreach plus SMS text messaging to SMS text with LHW support. (2) Conduct in-depth prospective investigation of sociocultural, ethical and behavioral factors related to COVID-19 testing in Chinese, Hmong and Vietnamese American over-time. In addition, factors affecting acceptance for vaccination research trial participation and vaccination uptake and how vaccination acceptance is associated with COVID-19 testing uptake will be explored.

02

Conditions studied

  • Educational Activities

Browse trials for

Keywords

  • COVID-19 Testing
  • COVID-19 Vaccination
  • Asian Americans
  • Peer Education
  • Immigrants
  • Chinese American
  • Hmong American
  • Vietnamese American
03

In context

COVID-19

7,638 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's enrollment of 247 is above the median of 100 across 4,098 interventional studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

University of California, San Francisco is the lead sponsor of 2,132 studies on the registry; 375 are open to participants now.

Of its 262 completed or terminated interventional studies of FDA-regulated products, 196 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • age 18 and older
  • self-identify as Chinese, Hmong or Vietnamese
  • able to read and/or speak: English, Chinese (Cantonese/Mandarin), Hmong or Vietnamese;
  • have access to a mobile phone to receive SMS text messages

Exclusion criteria

Exclusion Criteria:

  • unwilling to receive SMS text messages from the project
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
247 participants (actual)

Study arms

  • Active comparator
    Text Messaging Only

    Participants will receive a weekly SMS Text or instant message on a topic related to COVID-19 testing over 12 weeks. In addition, participants will receive as-needed messages on updates of COVID-19 testing related information. The messages will be responsive to the rapid evolving developments and changes related to COVID-19 testing guidelines. Some of the messages will include a link to allow participants to get to the entire message/information on the study website.

    Behavioral: Text Messaging Only

  • Experimental
    INFORMED

    Participants will receive a weekly SMS Text or instant message on a topic related to COVID-19 testing as described in the "Text Messaging Only." In addition, participants will receive a Lay Health Worker (LHW) Educational Outreach Program, which includes 2 group sessions via video calls like Zoom or another video conferencing platform and 2 follow-up contacts via telephone, text or other media assignment.

    Behavioral: INFORMED

Interventions

  • BehavioralText Messaging Only

    Active Comparator

  • BehavioralINFORMED

    Experimental

06

What researchers measure

Primary outcomes

  1. Decisional Conflict for Getting Tested for COVID-19

    Decision conflict is measured by the 4-item Decision Making Conflict (SURE) test which asks whether participants: 1) know enough about benefits and harm; 2) clear about which benefits and harms matter most; 3) have enough support/advice to make a choice; and 4) feel sure about the best choice regarding getting tested for COVID-19. Each item is scored either 0 (unsure) or 1(sure). The total score ranges from 0 to 4. Higher scores indicate 'more sure,' lower scores indicate higher decisional conflict.

    Time frame: Week 16

Secondary outcomes

  1. Tested for COVID-19 During the Past Month

    Participants are asked to self-report whether they have been tested for COVID-19 in the past 30 days

    Time frame: Week 16

  2. COVID-19 Testing Intention

    Proportion of participants who "agreed" or "strongly agreed" to the statement "I plan to get tested as often as needed."

    Time frame: Week 16

Other outcomes

  1. Decisional Conflicts for Getting Vaccinated for COVID-19 Score

    Decision conflicts is measured by the 4-item SURE test which asks whether participants: 1) know enough about benefits and harm; 2) clear about which benefits and harms matter most; 3) have enough support/advice to make a choice; and 4) feel sure about the best choice regarding getting vaccinated for COVID-19. Each item is scored either 0 (unsure) or 1 (sure). The total score ranges from 0 to 4. Higher score indicates lower decisional conflicts (or more sure); lower score indicates higher decisional conflicts.

    Time frame: Week 16

07

Results

Posted May 14, 2025

Participant flow

Participants were recruited by 3 community-based agencies primarily through trained lay health workers.

Participant flow — Overall Study
MilestoneText Messaging OnlyINFORMED
Started121126
Completed119117
Not completed29
Withdrew: Withdrawal by subject25
Withdrew: Lost to follow-up04

Outcome measures

PrimaryDecisional Conflict for Getting Tested for COVID-19

Decision conflict is measured by the 4-item Decision Making Conflict (SURE) test which asks whether participants: 1) know enough about benefits and harm; 2) clear about which benefits and harms matter most; 3) have enough support/advice to make a choice; and 4) feel sure about the best choice regarding getting tested for COVID-19. Each item is scored either 0 (unsure) or 1(sure). The total score ranges from 0 to 4. Higher scores indicate 'more sure,' lower scores indicate higher decisional conflict.

Time frame:
Week 16
Reported as:
Mean · score on a scale
Decisional Conflict for Getting Tested for COVID-19
score on a scaleText Messaging OnlyINFORMED
Decisional Conflict for Getting Tested for COVID-193.89 ± 0.373.96 ± 0.24
Statistical analysis
  • Text Messaging Only vs INFORMED · Mixed Models Analysis · p = 0.4471 · Mean difference (net): 0.08540 · 95% CI -0.1352 to 0.3060
SecondaryTested for COVID-19 During the Past Month

Participants are asked to self-report whether they have been tested for COVID-19 in the past 30 days

Time frame:
Week 16
Reported as:
Count of participants · Participants
Tested for COVID-19 During the Past Month
ParticipantsText Messaging OnlyINFORMED
Tested Tested4646
Not Tested (or missing)7580
Statistical analysis
  • Text Messaging Only vs INFORMED · Mixed Models Analysis · p = <0.05 · Odds ratio (or): 0.8378 · 95% CI 0.4284 to 1.6385Adjusted odds ratio
SecondaryCOVID-19 Testing Intention

Proportion of participants who "agreed" or "strongly agreed" to the statement "I plan to get tested as often as needed."

Time frame:
Week 16
Reported as:
Count of participants · Participants
COVID-19 Testing Intention
ParticipantsText Messaging OnlyINFORMED
Agree/Strongly Agree8490
Do not Agree3226
Statistical analysis
  • Text Messaging Only vs INFORMED · Mixed Models Analysis · p = <0.05 · Odds ratio (or): 1.4306 · 95% CI 0.6166 to 3.3192Adjusted odds ratio
Other pre-specifiedDecisional Conflicts for Getting Vaccinated for COVID-19 Score

Decision conflicts is measured by the 4-item SURE test which asks whether participants: 1) know enough about benefits and harm; 2) clear about which benefits and harms matter most; 3) have enough support/advice to make a choice; and 4) feel sure about the best choice regarding getting vaccinated for COVID-19. Each item is scored either 0 (unsure) or 1 (sure). The total score ranges from 0 to 4. Higher score indicates lower decisional conflicts (or more sure); lower score indicates higher decisional conflicts.

Time frame:
Week 16
Reported as:
Mean · score on a scale
Decisional Conflicts for Getting Vaccinated for COVID-19 Score
score on a scaleText Messaging OnlyINFORMED
Decisional Conflicts for Getting Vaccinated for COVID-19 Score3.87 ± 0.473.98 ± 0.13
Statistical analysis
  • Text Messaging Only vs INFORMED · Mean difference (final values): 0.08661 · 95% CI -0.07311 to 0.2463Adjusted for Demographics, COVID Cases Per 100,000 Population, Test Access, Social Network, Knowledge, and Test Value with random intercepts for Dyad and Individual

Adverse events

Collected over 16 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Text Messaging Only0/121 (0%)0/121 (0%)0/121 (0%)
INFORMED0/126 (0%)0/126 (0%)0/126 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Text Messaging OnlyINFORMEDTotal
<=18 years000
Between 18 and 65 years98111209
>=65 years211132
Sex: Female, Male
Sex: Female, Male(Participants)Text Messaging OnlyINFORMEDTotal
Female7177148
Male494998
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Text Messaging OnlyINFORMEDTotal
American Indian or Alaska Native000
Asian121126247
Native Hawaiian or Other Pacific Islander000
Black or African American000
White000
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Text Messaging OnlyINFORMEDTotal
United States121126247
Participation mode
Participation mode(Participants)Text Messaging OnlyINFORMEDTotal
Individual6368131
Dyad5858116
Education
Education(Participants)Text Messaging OnlyINFORMEDTotal
High School or Less/ Preferred Not to Answer5545100
Some college/ Technical or Vocational School354378
Bachelor's Degree or Higher303868
Marital Status
Marital Status(Participants)Text Messaging OnlyINFORMEDTotal
Married/Living with Partner6983152
Single/Preferred Not to Answer503888
Household Description
Household Description(Participants)Text Messaging OnlyINFORMEDTotal
Family including kids6766133
Multigenerational122638
No kids/Other413475

18 further baseline measures are reported on the registry.

08

Study locations

3 sites
  • The Fresno Center
    Fresno, California 93727, United States
  • Chinese Community Health Resource Center
    San Francisco, California 94133, United States
  • Immigrant Resettlement & Cultural Center Inc
    San Jose, California 95110, United States
09

References and documents

Publications

  • Cheng J, Tsoh JY, Guan A, Luu M, Nguyen IV, Tan R, Thao C, Yu E, Lor D, Pham M, Choi J, Kim M, Stewart SL, Burke NJ. Engaging Asian American Communities During the COVID-19 Era Tainted With Anti-Asian Hate and Distrust. Am J Public Health. 2022 Nov;112(S9):S864-S868. doi: 10.2105/AJPH.2022.306952. Epub 2022 Sep 15. No abstract available. PubMed 36108257 ↗

Study documents

  • Protocol and statistical analysis plan · Mar 15, 2025
  • Informed consent form · Jan 4, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — De-identified data will be shared upon request and data use agreement must be signed.

Supporting information: Icf

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04893265
Lead sponsor
University of California, San Francisco
Collaborators
Chinese Community Health Resource Center, University of California, Davis, University of California, Merced, National Institute on Drug Abuse (NIDA)
Responsible party
Sponsor
First posted
May 19, 2021
Start date
Sep 30, 2021
Primary completion
Jan 3, 2023
Completion
Jun 30, 2024
Results posted
May 14, 2025
Last update
May 14, 2025

Study contacts

Janice Y Tsoh, PhD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion